Royalty Security, LLC
Records under this name other than the patents Royalty Security, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 18 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,045,970 | Methods of Use of Cyclopamine Analogs Lapsed on the fee record Ended Aug 14, 2026 · High confidence | Lapsed on the fee record | Ended Aug 14, 2026 | High confidence |
| US 8,716,479 | Methods for stereoselective reduction Lapsed on the fee record Ended May 6, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 6, 2026 | From the USPTO record |
| US 7,230,004 | Cyclopamine analogues and methods of use thereof Term ended Term ended Oct 25, 2025 · From the USPTO record | Term ended | Term ended Oct 25, 2025 | From the USPTO record |
| US 7,407,967 | Cyclopamine analogues and methods of use thereof Term ended Term ended Aug 26, 2025 · From the USPTO record | Term ended | Term ended Aug 26, 2025 | From the USPTO record |
| US 7,875,628 | Cyclopamine analogues and methods of use thereof Term ended Ended no later than Aug 26, 2025 · From the USPTO record | Term ended | Ended no later than Aug 26, 2025 | From the USPTO record |
| US 8,236,956 | Cyclopamine analogues and methods of use thereof Lapsed on the fee record Ended Aug 7, 2024 · From the USPTO record | Lapsed on the fee record | Ended Aug 7, 2024 | From the USPTO record |
| US 8,431,566 | Cyclopamine lactam analogs and methods of use thereof Lapsed on the fee record Ended Apr 30, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 30, 2021 | From the USPTO record |
| US 8,426,436 | Heterocyclic cyclopamine analogs and methods of use thereof Lapsed on the fee record Ended Apr 23, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 23, 2021 | From the USPTO record |
| US 8,293,760 | Cyclopamine lactam analogs and methods of use thereof Lapsed on the fee record Ended Oct 23, 2020 · From the USPTO record | Lapsed on the fee record | Ended Oct 23, 2020 | From the USPTO record |
| US 7,994,191 | Heterocyclic cyclopamine analogs and methods of use thereof Lapsed on the fee record Ended Aug 9, 2019 · From the USPTO record | Lapsed on the fee record | Ended Aug 9, 2019 | From the USPTO record |